Nourishing GLP-1 Therapy for Obesity

This academic article, “Nutritional priorities to support GLP‐1 therapy for obesity,” is a joint advisory from several prominent American health organizations. It examines the use of GLP-1 receptor agonists (GLP-1s) for obesity treatment, highlighting their efficacy in weight reduction and other clinical benefits while also addressing significant challenges like gastrointestinal side effects, potential nutrient deficiencies, and loss of muscle and bone mass. The authors […]

GLP-1 Less Frequent Dosing May Maintain Weight Loss

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists is an effective and cost-saving strategy for long-term weight maintenance. Medscape Medical News

US administration will set targets to slash drug prices

What’s happened? On May 12th US president Donald Trump issued an executive order (EO) announcing plans to drastically lower prescription drug prices in the country. The order kickstarts negotiations that aim to force pharmaceutical companies to cut their US prices to match those charged in other developed countries, on a “most-favoured nation” basis. While the […]

Biocon gets CDSCO nod for generic diabetes medication

Biocon has secured Indian regulatory approval for its generic Liraglutide drug substance and product, a version of Victoza, for treating Type 2 Diabetes in adults and children over 10. CEO Siddharth Mittal highlighted the importance of this vertically integrated GLP-1 drug in expanding access for diabetes patients in India, where cases are rapidly increasing.